Role of Microbiota in Pathogenesis and Management of Viral Hepatitis

被引:33
作者
Sehgal, Rashi [1 ]
Bedi, Onkar [1 ]
Trehanpati, Nirupma [1 ]
机构
[1] Inst Liver & Biliary Sci, Dept Mol & Cellular Med, New Delhi, India
关键词
hepatitis; fecal microbiota transplantation; gut microbiota; lipopolysaccharides (LPS); probiotic; bacteria; GUT MICROBIOTA; THERAPEUTIC TARGET; LIVER; CIRRHOSIS; TRANSPLANTATION; INFECTION; EXPRESSION; COMMENSAL; BUTYRATE; BACTERIA;
D O I
10.3389/fcimb.2020.00341
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis is a condition that can be self-limiting or can progress to fibrosis (scarring), cirrhosis, or liver cancer. These days, gut microbiota becomes an important part of our immune system, which is important for disease progression or recovery. Translocation of gut microbial and metabolic products causes intestinal inflammation by modulating immune cells leading to impairment of the primary barrier. But there are limited studies discussing pathogenesis and management of hepatitis with gut microbiota. In this review, we have discussed the role of gut microbiota in pathogenesis and management of various hepatitis, especially hepatitis B and C. We have discussed the role of bacterial products, LPS-TLR4 pathway, and unmethylated CpG DNA, which ultimately affects downstream NF-kB signaling in hepatitis. Finally, we have discussed the role of fecal microbiota transplantation in the management of hepatitis.
引用
收藏
页数:8
相关论文
共 64 条
[11]   Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial [J].
Dhiman, Radha K. ;
Rana, Baldev ;
Agrawal, Swastik ;
Garg, Ashish ;
Chopra, Madhu ;
Thumburu, Kiran K. ;
Khattri, Amit ;
Malhotra, Samir ;
Duseja, Ajay ;
Chawla, Yogesh K. .
GASTROENTEROLOGY, 2014, 147 (06) :1327-+
[12]   Kupffer Cells in the Liver [J].
Dixon, Laura J. ;
Barnes, Mark ;
Tang, Hui ;
Pritchard, Michele T. ;
Nagy, Laura E. .
COMPREHENSIVE PHYSIOLOGY, 2013, 3 (02) :785-797
[13]   Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection [J].
Dolganiuc, Angela ;
Norkina, Oxana ;
Kodys, Karen ;
Catalano, Donna ;
Bakis, Gennadiy ;
Marshall, Christopher ;
Mandrekar, Pranoti ;
Szabo, Gyongyi .
GASTROENTEROLOGY, 2007, 133 (05) :1627-1636
[14]   Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward) [J].
Dore, G. J. ;
Ward, J. ;
Thursz, M. .
JOURNAL OF VIRAL HEPATITIS, 2014, 21 :1-4
[15]   Possibility of Adoptive Immunotherapy With Peripheral Blood-derived CD3-CD56+ and CD3+CD56+ Cells for Inducing Antihepatocellular Carcinoma and Antihepatitis C Virus Activity [J].
Doskali, Marlen ;
Tanaka, Yuka ;
Ohira, Masahiro ;
Ishiyama, Kohei ;
Tashiro, Hirotaka ;
Chayama, Kazuaki ;
Ohdan, Hideki .
JOURNAL OF IMMUNOTHERAPY, 2011, 34 (02) :137-146
[16]   Intestinal Permeability and Its Regulation by Zonulin: Diagnostic and Therapeutic Implications [J].
Fasano, Alessio .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (10) :1096-1100
[17]   Breast Cancer and Its Relationship with the Microbiota [J].
Fernandez, Mariana F. ;
Reina-Perez, Iris ;
Manuel Astorga, Juan ;
Rodriguez-Carrillo, Andrea ;
Plaza-Diaz, Julio ;
Fontana, Luis .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (08)
[18]   Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice [J].
Ferrere, Gladys ;
Wrzosek, Laura ;
Cailleux, Frederic ;
Turpin, Williams ;
Puchois, Virginie ;
Spatz, Madeleine ;
Ciocan, Dragos ;
Rainteau, Dominique ;
Humbert, Lydie ;
Hugot, Cindy ;
Gaudin, Francoise ;
Noordine, Marie-Louise ;
Robert, Veronique ;
Berrebi, Dominique ;
Thomas, Muriel ;
Naveau, Sylvie ;
Perlemuter, Gabriel ;
Cassard, Anne-Marie .
JOURNAL OF HEPATOLOGY, 2017, 66 (04) :806-815
[19]  
Fooladi AAI, 2010, IRAN J MICROBIOL, V2, P135
[20]   MAIT cells: a novel therapeutic target for alcoholic liver disease? [J].
Gao, Bin ;
Ma, Jing ;
Xiang, Xiaogang .
GUT, 2018, 67 (05) :784-786